Phase 2 Trial of Neoadjuvant Chemotherapy and Transoral Endoscopic Surgery With Risk-Adapted Adjuvant Therapy for Squamous Cell Carcinoma of the Head and Neck

Cancer - United States
doi 10.1002/cncr.31526
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Adjuvant Chemotherapy for Advanced Head and Neck Squamous Cell Carcinoma

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2014English

Adjuvant Chemotherapy (Nedaplatin/Uft) After Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Journal of Otolaryngology of Japan
Otorhinolaryngology
2006English

Induction Chemotherapy With Cis-Platinum and 5-Fluorouracil for Squamous Cell Carcinoma of the Head and Neck

British Journal of Cancer
Cancer ResearchOncology
1986English

Transoral Endoscopic Head and Neck Surgery (eHNS) for Minor Salivary Gland Tumors of the Oropharynx

Cancers of the Head & Neck
2017English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Combination Chemotherapy of Advanced Squamous Carcinoma of the Head and Neck

Acta Radiologica: Therapy, Physics, Biology
1977English

When Is Chemotherapy in Head and Neck Squamous Cell Carcinoma Not Indicated?

European Archives of Oto-Rhino-Laryngology
MedicineOtorhinolaryngology
2014English

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Journal of Skin Cancer
DermatologyOncology
2011English

Final Safety Results of a Phase 1 Clinical Trial of Afatinib in Combination With Docetaxel and Postoperative Radiation Therapy for High-Risk Squamous Cell Carcinoma of the Head and Neck

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy